Fiona Baine

Fiona Baine

Auto-generated profile, based on publicly available information

Fiona Baine

Division of Human Genetics, National Health Laboratory Service and Faculty of Health Sciences, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2018 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Closed access
PDF file
CKChris Kay
Chris Kay
JCJennifer A. Collins
Jennifer A. Collins
GWGalen E.B. Wright
Galen E.B. Wright
FBFiona Baine
Fiona Baine
ZMZosia Miedzybrodzka
Zosia Miedzybrodzka
MHMichael R. Hayden
Michael R. Hayden

6 March 2013 in European Journal of Human Genetics
Verified
Journal Article
Closed access
FBFiona K Baine
Fiona K Baine
CKChris Kay
Chris Kay
MKMaria E Ketelaar
Maria E Ketelaar
JCJennifer A Collins
Jennifer A Collins
ASAlicia Semaka
Alicia Semaka
MHMichael R. Hayden
Michael R. Hayden

17 February 2016 in Neuroepidemiology
Verified
Journal Article
Closed access
FBFiona K. Baine
Fiona K. Baine
AKAmanda Krause
Amanda Krause
LGL. Jacquie Greenberg
L. Jacquie Greenberg
Background: Huntington disease (HD) has most recently been estimated to affect between 10.6 and 13.7 per 100,000 individuals in European populations. However, prevalence is known to differ geographically. In South Africa, the only published estimates are from a survey performed in the 1970s, an era when the disease was believed to be rare or absent in black individuals and molecular confirmation was absent. The disease phenotype in South Africa is currently attributable to mutations in both the huntington and junctophilin-3 genes, which underlie the well-known HD and the rarer HD-like 2 (HDL2) respectively. This study aimed at providing improved minimum estimates of disease frequency in South Africa, based on molecular genetic testing data. Methods: A review of all testing records for HD and HDL2 over a 20-year period was undertaken. HDL2 is virtually indistinguishable on clinical features, thus necessitating its inclusion. Results: Based on molecular diagnostic records, minimum estimates of disease frequency are: 5.1, 2.1 and 0.25 (per 100,000 individuals) for the white, mixed ancestry and black population groups respectively. Conclusion: Although ascertainment remains incomplete, these minimum estimates suggest that disease frequencies are significantly higher than those previously reported in South Africa.

25 June 2009 in Wilhelm Roux' Archiv für Entwicklungsmechanik der Organismen
Verified
Journal Article
Closed access
PDF file
NINicola Illing
Nicola Illing
CKCornelia Klak
Cornelia Klak
CJCheryl Johnson
Cheryl Johnson
DBDenise Brito
Denise Brito
NNNuria Negrao
Nuria Negrao
LRLaura Roden
Laura Roden

19 December 2023 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
AKAmanda Krause
Amanda Krause
DADavid G. Anderson
David G. Anderson
AFAline Ferreira-Correia
Aline Ferreira-Correia
JDJessica Dawson
Jessica Dawson
FBFiona Baine-Savanhu
Fiona Baine-Savanhu
RMRussell L. Margolis
Russell L. Margolis

1 July 2018 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
FBFiona K. Baine
Fiona K. Baine
NPNabeelah Peerbhai
Nabeelah Peerbhai
AKAmanda Krause
Amanda Krause